--- title: "Zurich Insurance Group (SWX:ZURN) Stock Valuation After Dividend Appeal In Uncertain European Markets" type: "News" locale: "en" url: "https://longbridge.com/en/news/289667091.md" description: "Zurich Insurance Group (SWX:ZURN) is highlighted as a top European dividend stock with a 4.40% yield, trading at CHF563.8 against an estimated fair value of CHF580.51, suggesting modest undervaluation. Analysts project 2.5% annual revenue growth and margin expansion over three years. However, the stock trades at a P/E of 15.5x, higher than the sector average but lower than peers, creating mixed valuation signals regarding future rerating potential." datetime: "2026-06-13T13:23:59.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/289667091.md) - [en](https://longbridge.com/en/news/289667091.md) - [zh-HK](https://longbridge.com/zh-HK/news/289667091.md) --- # Zurich Insurance Group (SWX:ZURN) Stock Valuation After Dividend Appeal In Uncertain European Markets ## Event-driven focus on Zurich Insurance Group (SWX:ZURN) Zurich Insurance Group (SWX:ZURN) has come into focus after being highlighted as a top European dividend stock, with a 4.40% yield, at a time when the STOXX Europe 600 Index has recently declined. See our latest analysis for Zurich Insurance Group. The current share price of CHF563.8 sits alongside a 4.8% 90 day share price return and a 6.0% one year total shareholder return, while the five year total shareholder return of 95.8% reflects a strong longer term payoff profile. If Zurich Insurance Group has you thinking about long term compounders, it can be useful to widen the net and scan 103 top founder-led companies With the stock around CHF563.8, an intrinsic value estimate implying a sizeable discount, a modest premium to analyst targets and a 4.40% yield, the key question is whether the current valuation still represents an opportunity for investors or if the market is already pricing in future growth. ## Most Popular Narrative: 3% Undervalued With Zurich Insurance Group last closing at CHF563.8 against a narrative fair value of CHF580.51, the gap is small but still points to modest upside according to the most followed narrative built from analyst expectations. > _Analysts are assuming Zurich Insurance Group's revenue will grow by 2.5% annually over the next 3 years. Analysts assume that profit margins will increase from 9.3% today to 11.0% in 3 years time._ _Read the complete narrative._ Curious what sits behind that gentle uplift in fair value? The narrative leans heavily on steady revenue expansion, firmer margins and a future earnings multiple that has to compress from today. The tension between these inputs and the muted upside is exactly where the story gets interesting. **Result: Fair Value of CHF580.51 (UNDERVALUED)** Have a read of the narrative in full and understand what's behind the forecasts. However, this story can shift quickly if rising expenses do not translate into efficiency gains or if softer pricing in key lines pressures margins more than analysts expect. **Wall Street's queuing for one rocket.** While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page. ## Another View on Valuation The analyst narrative sees Zurich Insurance Group trading only modestly below a CHF580.51 fair value, yet on simple earnings terms the picture is different. The stock trades on a P/E of 15.5x, compared with 13x for the European insurance sector and a 20.1x peer average, while the fair ratio sits at 18.6x. That mix of richer pricing than the sector but cheaper levels than peers and the fair ratio leaves you weighing whether this is a margin of safety or a warning sign about how much rerating room is left. For a closer look at how these earnings multiples stack up against what the numbers imply, See what the numbers say about this price — find out in our valuation breakdown. SWX:ZURN P/E Ratio as at Jun 2026 ## Next Steps If the mixed signals in Zurich Insurance Group's story leave you undecided, do not wait too long to run the numbers yourself and stress test the assumptions that matter most to you. Then take a closer look at the 4 key rewards ## Looking for more investment ideas? Do not stop with a single stock when there are entire lists of opportunities tailored to different goals and risk levels waiting to be scanned. - Target higher income potential by reviewing companies screened as 482 dividend fortresses that focus on substantial payouts to shareholders. - Hunt for possible value opportunities by checking stocks filtered as 193 high quality undervalued stocks that pair quality fundamentals with appealing pricing. - Prioritise resilience by examining companies highlighted in the 285 resilient stocks with low risk scores that score well on stability and risk controls. _This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._ ### Valuation is complex, but we're here to simplify it. Discover if Zurich Insurance Group might be undervalued or overvalued with our detailed analysis, featuring **fair value estimates, potential risks, dividends, insider trades, and its financial condition.** Access Free Analysis ### Related Stocks - [ZURVY.US](https://longbridge.com/en/quote/ZURVY.US.md) - [RKLB.US](https://longbridge.com/en/quote/RKLB.US.md) ## Related News & Research - [Zurich Insurance Group (ZURVY) Projected to Post Quarterly Earnings on Tuesday](https://longbridge.com/en/news/285246258.md) - [Only 1 Stock Is the Indispensable Backbone of the $1.8 Trillion Space Economy — and It’s Not SpaceX](https://longbridge.com/en/news/289356019.md) - [Space stocks got crushed on SpaceX's big day. Is the sell-off a warning or a buying opportunity?](https://longbridge.com/en/news/289672012.md) - [Planet Labs stock plunged following its recent earnings call. Should investors buy the dip?](https://longbridge.com/en/news/289671809.md) - [A Look At Galenica (SWX:GALE) Valuation After Reaffirming Its 2026 Growth Outlook](https://longbridge.com/en/news/289104876.md)